ARTICLE | Company News
University of Colorado, NantWorks deal
November 3, 2014 8:00 AM UTC
The university granted NantWorks' NantBioscience subsidiary exclusive, worldwide rights to develop and commercialize cancer therapeutics and diagnostics targeting v-ral simian leukemia viral oncogene...